Longevity Biotech announces that the US Patent and Trademark Office has granted a key patent covering aspects of the Hybridtide® peptide technology platform

October 11, 2017 – Philadelphia, PA

Longevity Biotech announces that the US Patent and Trademark Office has granted a key patent covering aspects of the Hybridtide® peptide technology platform.